WINNING STRATEGIES WASHINGTON

Lobbying for DBV TECHNOLOGIES · Pharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $30,000.00 income · posted Apr 17, 2026

Lobbying activity 1

Health Issues

Innovation in medical therapies to treat childhood food allergies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem